27 studies found for:    "Diabetes Insipidus" [DISEASE]
Show Display Options
RSS Create an RSS feed from your search for:
"Diabetes Insipidus" [DISEASE]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Conditions: Diabetes Insipidus;   Diabetes Insipidus, Neurohypophyseal
Interventions: Drug: chlorpropamide;   Drug: desmopressin
2 Completed Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Condition: Nephrogenic Diabetes Insipidus
Interventions: Drug: sildenafil;   Drug: calcitonin;   Drug: hydrochlorothiazide/amiloride;   Drug: indomethacin;   Drug: Placebo for sildenafil;   Drug: placebo for calcitonin
3 Recruiting Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study
Condition: Diabetes Insipidus
Intervention:
4 Unknown  Study of Novel Types of Familial Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: desmopressin
5 Completed Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus, Nephrogenic
Intervention: Drug: chlorothiazide
6 Completed A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
Condition: Central Diabetes Insipidus
Interventions: Drug: Desmopressin Oral Melt;   Drug: Desmopressin intranasal
7 Completed Vasopressin Deficiency in Hemorrhagic Shock
Condition: Body Response to Trauma
Intervention: Other: Phlebotomy
8 Recruiting Oxytocin and Arginine Vasopressin in Pain Relief
Condition: Placebo Analgesia
Intervention:
9 Not yet recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
10 Completed The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration
Condition: Exercise Induced Hyponatremia
Interventions: Dietary Supplement: Gatorade Endurance Formula;   Other: ganirelix acetate
11 Completed 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
Condition: Kidney Failure
Interventions: Drug: DDAVP;   Drug: placebo
12 Completed Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Inappropriate ADH Syndrome;   Hyponatremia
Intervention: Drug: SR121463B
13 Completed Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Inappropriate ADH Syndrome;   Hyponatremia
Intervention: Drug: SR121463B
14 Completed Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Syndrome of Inappropriate ADH (SIADH) Secretion;   Hyponatremia
Intervention: Drug: satavaptan (SR121463B)
15 Recruiting Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B;   Biopsy;   Hemodialysis
Intervention: Procedure: Percutaneous liver biopsy
16 Unknown  GLP Analogs for Diabetes in Wolfram Syndrome Patients
Conditions: Diabetes Mellitus Associated With Genetic Syndrome;   Wolfram Syndrome
Intervention: Drug: Exenatide
17 Unknown  Vasopressin in Traumatic Hemorrhagic Shock Study
Conditions: Shock;   Hypovolemia;   Hemorrhagic Shock
Interventions: Drug: Pressyn, arginine vasopressin;   Drug: Saline placebo
18 Unknown  Desmopressin in Cardiac Surgery
Conditions: Hemorrhage;   Blood Loss, Surgical;   Postoperative Hemorrhage
Interventions: Drug: Desmopressin (DDAVP);   Other: Placebo Comparator
19 Terminated A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
Conditions: Hyponatremia;   Inappropriate ADH Syndrome
Interventions: Drug: satavaptan (SR121463);   Drug: placebo
20 Completed The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)
Conditions: Stroke;   Transient Ischemic Attack
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years